Well, if you purchased generic prescription drugs from 2009 to 2019, you could be getting some money back. Mississippi Attorney General Lynn Fitch says there’s *** multi-state settlement with the generic drug maker Glenmark. It was over allegations the company helped inflate prices. The $29.6 million dollar settlement sends nearly $237,000 to Mississippi. If you bought certain generic medications between 2009 and 2019, go to WAPT.com to find out if you’re eligible for compensation.
Mississippi joins $29.6 million Glenmark settlement over generic drug price manipulation
Updated: 11:15 PM CDT Jul 15, 2026
Attorney General Lynn Fitch announced that Mississippi is part of a coalition of 48 states and territories that reached a $29.6 million settlement with Glenmark Pharmaceuticals to resolve allegations of price manipulation and anti-competitive practices involving generic prescription drugs.”Generic drugs are supposed to be a more affordable alternative, and they are often a lifeline for Americans who rely on them,” Fitch said in a statement. “We are holding the companies that kept prices artificially high accountable for taking advantage of families, and I encourage any Mississippian who thinks they may be eligible to register today.” The Glenmark settlement follows previous settlements with Lannett, Bausch, Apotex, and Heritage, which collectively totaled $66.95 million. Individuals who purchased generic prescription drugs manufactured by Glenmark, Lannett, Bausch, Apotex, or Heritage between May 2009 and December 2019 may be eligible for compensation. To determine eligibility, individuals can call 1-866-290-0182 (toll-free), email info@AGGenericDrugs.com, or visit AGGenericDrugs.com. In addition to Mississippi, the settlement includes the following states and territories: Alaska, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, U.S. Virgin Islands, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming, and Puerto Rico.
JACKSON, Miss. —
Attorney General Lynn Fitch announced that Mississippi is part of a coalition of 48 states and territories that reached a $29.6 million settlement with Glenmark Pharmaceuticals to resolve allegations of price manipulation and anti-competitive practices involving generic prescription drugs.
“Generic drugs are supposed to be a more affordable alternative, and they are often a lifeline for Americans who rely on them,” Fitch said in a statement. “We are holding the companies that kept prices artificially high accountable for taking advantage of families, and I encourage any Mississippian who thinks they may be eligible to register today.”
The Glenmark settlement follows previous settlements with Lannett, Bausch, Apotex, and Heritage, which collectively totaled $66.95 million. Individuals who purchased generic prescription drugs manufactured by Glenmark, Lannett, Bausch, Apotex, or Heritage between May 2009 and December 2019 may be eligible for compensation.
To determine eligibility, individuals can call 1-866-290-0182 (toll-free), email info@AGGenericDrugs.com, or visit AGGenericDrugs.com.
In addition to Mississippi, the settlement includes the following states and territories: Alaska, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, U.S. Virgin Islands, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming, and Puerto Rico.